Pharmacokinetics and pharmacodynamics of the novel PAR-1 antagonist vorapaxar in patients with end-stage renal disease
暂无分享,去创建一个
Lei Ma | L. Jennings | W. Kraft | D. Cutler | T. Kosoglou | P. Statkevich | B. Kumar | F. Xuan | James E. Schiller | R. B. Langdon | Lei Ma | D. Cutler